Check your eligibility now & get in touch with a study center

V6.15 Smoke Testing

Testing

Call 1800-9860-568 now to find out if you are eligible.

Are you a patient with moderate to severe plaque psoriasis?

Have you treated your condition with adalimumab (Humira®) and did it become less effective on your plaque psoriasis within the last 6 months? If so, you may be eligible for a clinical research study with etanercept (Enbrel®) which is also approved for moderate to severe plaque psoriasis. Qualified participants will receive an initial consultation, study-related examinations, and study medication.

Am I eligible? Learn More

Your Journey

Receiving the medication

You would receive etanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept, as well as study related medical care, is provided at no cost.

Visiting the study site

Study participation involves approximately 8 visits to your local study center over 6 to 7 months.

Follow-up

There would also be a follow-up telephone call 30days after completing the study. No visits are required after participation is complete.